One potential mechanism for the observed effect is that the apoptotic tumor cells may be taken up by antigen-presenting cells, resulting in the activation of tumor-specific CD8+ T cells (so called cross-priming mechanism). The gene discussed is CD8A; the disease is neoplasm.